company background image
MCAP logo

MedCap OM:MCAP Stock Report

Last Price

kr387.50

Market Cap

kr5.7b

7D

4.4%

1Y

56.9%

Updated

26 Mar, 2024

Data

Company Financials

MCAP Stock Overview

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout.

MCAP fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for MCAP from our risk checks.

MedCap AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MedCap
Historical stock prices
Current Share Pricekr387.50
52 Week Highkr409.00
52 Week Lowkr246.00
Beta0.67
1 Month Change-0.64%
3 Month Change12.97%
1 Year Change56.88%
3 Year Change85.41%
5 Year Change378.40%
Change since IPO3,736.63%

Recent News & Updates

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15
MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

Dec 21
Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

Recent updates

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15
MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

Dec 21
Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

May 06
Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

Nov 23
These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Sep 21
We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

Apr 29
Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Feb 01
MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Aug 03
Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

May 27
Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Apr 07
Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Mar 15
Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Feb 26
Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

MedCap (STO:MCAP) Could Easily Take On More Debt

Feb 08
MedCap (STO:MCAP) Could Easily Take On More Debt

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22
Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07
Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22
MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08
If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23
Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Shareholder Returns

MCAPSE Life SciencesSE Market
7D4.4%5.0%1.8%
1Y56.9%19.8%19.0%

Return vs Industry: MCAP exceeded the Swedish Life Sciences industry which returned 16.3% over the past year.

Return vs Market: MCAP exceeded the Swedish Market which returned 17.8% over the past year.

Price Volatility

Is MCAP's price volatile compared to industry and market?
MCAP volatility
MCAP Average Weekly Movement5.8%
Life Sciences Industry Average Movement6.8%
Market Average Movement6.0%
10% most volatile stocks in SE Market12.7%
10% least volatile stocks in SE Market3.4%

Stable Share Price: MCAP has not had significant price volatility in the past 3 months.

Volatility Over Time: MCAP's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001514Anders Dahlberghttps://www.medcap.se

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe.

MedCap AB (publ) Fundamentals Summary

How do MedCap's earnings and revenue compare to its market cap?
MCAP fundamental statistics
Market capkr5.74b
Earnings (TTM)kr172.20m
Revenue (TTM)kr1.59b

33.3x

P/E Ratio

3.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCAP income statement (TTM)
Revenuekr1.59b
Cost of Revenuekr650.30m
Gross Profitkr937.10m
Other Expenseskr764.90m
Earningskr172.20m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 03, 2024

Earnings per share (EPS)11.63
Gross Margin59.03%
Net Profit Margin10.85%
Debt/Equity Ratio11.1%

How did MCAP perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.